Trial Profile

A Phase 2, Multi-center, Randomized, Double-Blind, Parallel-Group, Dose-Finding Study to Assess the Effect of Four Doses of MM-120 (LSD D-Tartrate) for the Treatment of Anxiety Symptoms

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 07 Sep 2025

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

04 Sep 2025 Results published in a MindMed media release
04 Sep 2025 According to a MindMed media release, the company today announced that JAMA has published the full results from its positive Phase 2b study of MM120 in adults with moderate-to-severe generalized anxiety disorder (GAD).
11 Dec 2024 According to a MindMed media release, data from this study were presented at the ACNP 2024 Congress taking place December 8-11 in Phoenix, AZ.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com